Impli to accelerate real-time hormone monitoring technology at Birmingham’s PHTA
Impli, a pioneering health technology company developing implantable biosensors for real-time hormone monitoring, has become the first commercial lab resident at Birmingham’s PHTA, targeting team growth, human trials and manufacturing readiness. Focusing initially on improving women’s health, Impli’s platform is designed to help clinicians and patients understand hormonal fluctuations to make better-informed treatment decisions […]